1,620 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. Global epidemiology of heart failure
3. Cardiac wasting in patients with cancer
4. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
5. GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?
6. Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials
7. Chitosan-Based Adsorbents and Catalysts for Removal of Toxic Pollutants from Water and Wastewater
8. Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis
9. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
10. Nanomaterials for the Catalytic Degradation and Detection of Microplastics: A Review
11. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
12. Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
13. The need for increased pragmatism in cardiovascular clinical trials
14. Employee Satisfaction and Engagement Are Crucial for Organizational Success
15. Contributors
16. Chitosan-based composites for oil-contaminated water treatment
17. Green adsorbents and solvents in food analysis
18. Environmental impact of nanomaterials
19. Electrospun fibers: promising materials for oil water separation
20. Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
21. Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial
22. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
23. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
24. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
25. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
26. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
27. Nano-based remediation strategies for micro and nanoplastic pollution
28. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
29. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
30. Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
31. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
32. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis
33. Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study
34. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
35. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
36. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
37. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
38. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
39. Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation
40. Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results
41. Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials
42. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis
43. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
44. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure
45. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)
46. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
47. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
48. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
49. Predicting and preventing heart failure in type 2 diabetes
50. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.